News Focus
News Focus
icon url

Honeycomb777

08/10/17 8:47 AM

#11095 RE: Biotech Pharmer #11093

UMMM - because Hikma is smart and locked INNV into a multiple year deal in order to utilize them ! Simple as that

That Novalere deal bought them 20,000 vendors of record (stores that can/will sell the nasal spray)


Face it Freak - this will continue to rise through Monday (and likely beyond). PERIOD

* A test of 15 cents is likely IMO
icon url

jtaylor68

08/10/17 6:09 PM

#11128 RE: Biotech Pharmer #11093

RB#1, read:

The Company’s relationship with WWPIL for FlutiCare™ allows Innovus Pharma to launch the product in the U.S. on a shorter timeline instead of waiting for the approval of the first ANDA. In addition, Innovus Pharma believes that having two manufacturers, of which WWPIL is the sole manufacturer for FlutiCare™ in the U.S. market, is an advantage to ensure continuous product availability.



So, to reiterate, they commit to batches until 2018/19, because West-Ward is there to bring FlutiCare to the US Americans exclusively.
The other ANDA will supply FlutiCare be for the rest of the world.
This also debunks your claim that the West-Ward deal is just an expensive temporary solution out of desperation.